Review
Open access
Jul 2026
Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy
This review provides a comprehensive overview of current and emerging biomarkers in TNBC, focusing on their role in the era of neoadjuvant chemo-immunotherapy and the challenges of integrating emerging biomarkers into routine clinical practice.
Mariarosaria D’Amato, M. Morritti, Franco Morelli et al.
· Frontiers in Oncology · 0 citations